Mind Cognita

About Our Company

Pioneering AI solutions to identify neurodegenerative diseases before symptoms manifest.

Mind Cognita harnesses advanced AI to provide early detection of neurodegenerative diseases through EEG analysis, retinal imaging, and wearable tech, ensuring efficient patient care.

Early diagnosis of neurodegenerative diseases through innovative tech and AI.

By integrating cutting-edge research from Mayo Clinic, Mind Cognita offers a revolutionary approach to predict Alzheimer’s, Parkinson’s, and Lewy body dementia five to ten years ahead of clinical signs.

Empowering patients with insights well before symptoms appear.

Our Journey

The Evolution of Mind Cognita

Founded by a team of neuroscientists and tech innovators, Mind Cognita emerged from groundbreaking research at the Mayo Clinic. Our vision is to transform neurodegenerative disease detection, enabling early interventions and improving patient outcomes. Using multimodal AI technology, we have developed proprietary methods for analyzing neurological data, leading to unparalleled accuracy in identifying at-risk individuals and shaping the future of neurological health.

Meet Our Team

Martha Oliver

Job Title

Andrea Taylor

Job Title

Diana David

Job Title

Join Us in Shaping the Future

Stay informed and take action towards early detection and better health outcomes for neurodegenerative diseases.

Get Started